Zurich Cantonal Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $95.7M | Buy |
522,155
+69,713
| +15% | +$12.8M | 0.21% | 90 |
|
|
2025
Q4 | $79.6M | Buy |
452,442
+104,038
| +30% | +$17M | 0.17% | 111 |
|
|
2025
Q3 | $48.8M | Buy |
348,404
+282,084
| +425% | +$38.1M | 0.11% | 156 |
|
|
2025
Q2 | $8.33M | Sell |
66,320
-121,483
| -65% | -$15.1M | 0.02% | 492 |
|
|
2025
Q1 | $25.7M | Buy |
187,803
+43,651
| +30% | +$6.24M | 0.07% | 243 |
|
|
2024
Q4 | $22M | Buy |
144,152
+74,503
| +107% | +$12.6M | 0.06% | 275 |
|
|
2024
Q3 | $13.5M | Sell |
69,649
-3,707
| -5% | -$776K | 0.04% | 367 |
|
|
2024
Q2 | $17M | Sell |
73,356
-1,999
| -3% | -$434K | 0.06% | 290 |
|
|
2024
Q1 | $16.2M | Sell |
75,355
-94,026
| -56% | -$22M | 0.06% | 298 |
|
|
2023
Q4 | $43.8M | Sell |
169,381
-45,019
| -21% | -$11.1M | 0.17% | 111 |
|
|
2023
Q3 | $55.1M | Buy |
214,400
+15,627
| +8% | +$4.18M | 0.24% | 76 |
|
|
2023
Q2 | $56.6M | Buy |
198,773
+17,253
| +10% | +$5.14M | 0.25% | 78 |
|
|
2023
Q1 | $50.5M | Buy |
181,520
+31,483
| +21% | +$8.71M | 0.25% | 80 |
|
|
2022
Q4 | $41.5M | Buy |
150,037
+47,302
| +46% | +$13.4M | 0.22% | 92 |
|
|
2022
Q3 | $27.4M | Buy |
102,735
+20,756
| +25% | +$4.41M | 0.16% | 123 |
|
|
2022
Q2 | $16.7M | Sell |
81,979
-11,389
| -12% | -$2.33M | 0.1% | 200 |
|
|
2022
Q1 | $19.7M | Sell |
93,368
-3,839
| -4% | -$835K | 0.1% | 188 |
|
|
2021
Q4 | $23.3M | Buy |
97,207
+19,344
| +25% | +$4.97M | 0.11% | 162 |
|
|
2021
Q3 | $22M | Buy |
77,863
+8,272
| +12% | +$2.71M | 0.12% | 167 |
|
|
2021
Q2 | $24.1M | Buy |
69,591
+6,401
| +10% | +$1.94M | 0.13% | 145 |
|
|
2021
Q1 | $17.7M | Sell |
63,190
-2,221
| -3% | -$599K | 0.11% | 181 |
|
|
2020
Q4 | $16M | Buy |
65,411
+91
| +0.1% | +$23.5K | 0.1% | 190 |
|
|
2020
Q3 | $18.5M | Sell |
65,320
-846
| -1% | -$236K | 0.13% | 147 |
|
|
2020
Q2 | $17.7M | Sell |
66,166
-9,017
| -12% | -$2.71M | 0.15% | 129 |
|
|
2020
Q1 | $23.8M | Buy |
75,183
+27,629
| +58% | +$8.38M | 0.22% | 84 |
|
|
2019
Q4 | $14.1M | Sell |
47,554
-5,897
| -11% | -$1.64M | 0.11% | 208 |
|
|
2019
Q3 | $12.4M | Buy |
53,451
+822
| +2% | +$191K | 0.1% | 216 |
|
|
2019
Q2 | $12.3M | Sell |
52,629
-28,873
| -35% | -$6.67M | 0.1% | 219 |
|
|
2019
Q1 | $19.3M | Sell |
81,502
-69,235
| -46% | -$21.8M | 0.17% | 133 |
|
|
2018
Q4 | $45.4M | Buy |
150,737
+14,191
| +10% | +$4.53M | 0.46% | 39 |
|
|
2018
Q3 | $48.2M | Sell |
136,546
-12,977
| -9% | -$4.47M | 0.41% | 41 |
|
|
2018
Q2 | $43.4M | Sell |
149,523
-30,151
| -17% | -$8.48M | 0.39% | 46 |
|
|
2018
Q1 | $49.2M | Buy |
179,674
+20,710
| +13% | +$6.43M | 0.45% | 37 |
|
|
2017
Q4 | $50.6M | Buy |
158,964
+29,597
| +23% | +$9.49M | 0.45% | 40 |
|
|
2017
Q3 | $40.5M | Buy |
129,367
+44,401
| +52% | +$13.1M | 0.38% | 53 |
|
|
2017
Q2 | $23.1M | Buy |
84,966
+4,389
| +5% | +$1.16M | 0.23% | 97 |
|
|
2017
Q1 | $22M | Sell |
80,577
-479
| -0.6% | -$135K | 0.22% | 106 |
|
|
2016
Q4 | $23M | Buy |
81,056
+24,966
| +45% | +$7.4M | 0.24% | 94 |
|
|
2016
Q3 | $17.6M | Buy |
56,090
+24,673
| +79% | +$7.31M | 0.18% | 121 |
|
|
2016
Q2 | $7.6M | Sell |
31,417
-3,218
| -9% | -$848K | 0.1% | 222 |
|
|
2016
Q1 | $9.02M | Buy |
34,635
+609
| +2% | +$161K | 0.11% | 185 |
|
|
2015
Q4 | $10.4M | Sell |
34,026
-29,865
| -47% | -$8.58M | 0.13% | 161 |
|
|
2015
Q3 | $18.6M | Buy |
63,891
+1,172
| +2% | +$387K | 0.26% | 85 |
|
|
2015
Q2 | $25.3M | Sell |
62,719
-4,463
| -7% | -$1.79M | 0.35% | 70 |
|
|
2015
Q1 | $28.4M | Buy |
67,182
+36,517
| +119% | +$14.4M | 0.39% | 66 |
|
|
2014
Q4 | $10.4M | Sell |
30,665
-3,030
| -9% | -$980K | 0.32% | 59 |
|
|
2014
Q3 | $11.1M | Sell |
33,695
-52,202
| -61% | -$17.2M | 0.37% | 50 |
|
|
2014
Q2 | $27.1M | Buy |
85,897
+5,043
| +6% | +$1.52M | 0.8% | 17 |
|
|
2014
Q1 | $24.7M | Sell |
80,854
-889
| -1% | -$282K | 0.76% | 16 |
|
|
2013
Q4 | $22.9M | Buy |
81,743
+20,025
| +32% | +$5.18M | 0.75% | 17 |
|
|
2013
Q3 | $14.9M | Sell |
61,718
-4,419
| -7% | -$989K | 0.51% | 34 |
|
|
2013
Q2 | $14.2M | Buy |
+66,137
| New | +$14.1M | 0.5% | 35 |
|
Other funds holding BIIB
VCM
VPM
Zurich Cantonal Bank's BIIB Position: Q1 2026 in Review
Zurich Cantonal Bank increased its Biogen (BIIB) stake by 15% in Q1 2026, buying an estimated $12.8M and bringing the position to 522,155 shares worth $95.7M. The position accounts for 0.21% of the portfolio, ranked #90.
Zurich Cantonal Bank first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Zurich Cantonal Bank held 522,155 shares of Biogen worth $95.7M as of Q1 2026.
- Zurich Cantonal Bank bought 69,713 Biogen shares in Q1 2026, an estimated $12.8M.
- Biogen made up 0.21% of Zurich Cantonal Bank's portfolio in Q1 2026, its #90 holding.
- Zurich Cantonal Bank first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.